Alteco Medical offers a medical device for extracorporeal blood purification. The product removes endotoxin (lipopolysaccharide, LPS) from the patient’s bloodstream, and is applied as an add-on therapy in sepsis to treat endotoxemia (high levels of endotoxin). This can help stabilize the patient in acute situations. Endotoxemia is often present in sepsis, a life-threatening condition and one of the most common causes of death in modern intensive care.

Quotes for Alteco Medical AB

Right Now

+/-
-0.018
%
−15,00%
Latest
0.102
High
0.102
Low
0.102
Volume
4 500
Turnover (SEK)
459
Market Value (MSEK)
5,8
Time (Latest trade)
2024-04-19 10:11

Board

CEO

  • Fredrik Jonsson

Chairperson of the Board

  • Anders Althin

Board

  • Charlotte Althin Hicks
  • Fredrik Jonsson
  • Mats Wahlström

Largest Owners

Name Capital % Votes % Date
Anders Althin 71,36 71,36 2024-03-26
Göran Erlandsson 3,63 3,63 2024-03-26
Avanza Pension 2,33 2,33 2024-03-26
Fredrik Jonsson 2,27 2,27 2024-03-26
Jarl Ingvar Andersson 0,58 0,58 2024-03-26
Magnus Lundberg 0,52 0,52 2024-03-26
Nordnet Pensionsförsäkring 0,52 0,52 2024-03-26
Fredrik Nerme 0,44 0,44 2024-03-26
Anders Berthag 0,44 0,44 2024-03-26
Handelsbanken Liv Försäkring AB 0,43 0,43 2024-03-26
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream